RARE CANCER PATIENTS
From 2012 to 2016, 75% of clinical trials did not specifically include any rare cancers.
As of 2018, 79% of cancer patients lacking approved targeted therapy have a rare cancer.
SHARE YOUR SUPPORT
Sample Tweets and Social Posts
Amplify the campaign by posting your support along with a picture of your bracelet because #RareIsntRare.
Today I’m wearing my support for the @SHEPHERDFound #RareIsntRare Campaign. Join me in demanding #equity for all #RareCancer #patients.
Did you know all #ChildhoodCancers are considered #RareCancers? They all deserve better. Join the @SHEPHERDFound #RareIsntRare campaign to change the system.
Survival shouldn't be determined by skin color, age, zip code, income, circumstance, or specific #cancer #diagnosis. Join the @SHEPHERDFound #RareIsntRare campaign to rethink #HealthJustice & elevate the voices of neglected & underserved #patient communities.
Every patient deserves the right to live - regardless of their diagnosis. Support the @SHEPHERDFound #RareIsntRare campaign to change the narrative around #RareCancers - so that no patient is left to die.
All patients deserve access to life-saving therapies, resources and funding. Join me in supporting the @SHEPHERDFound #RareIsntRare campaign to amplify the voices of the #RareCancer community.
igniting the conversation with our partner
BIRD & STONE
We are committed to ethically-made products that support organizations building a more equal world.
We believe in creating a community of changemakers, and leveraging our collective purchasing power to drive change.